25 reports of this reaction
3.2% of all ARNICA MONTANA reports
#3 most reported adverse reaction
HEADACHE is the #3 most commonly reported adverse reaction for ARNICA MONTANA, manufactured by Laboratoires Boiron. There are 25 FDA adverse event reports linking ARNICA MONTANA to HEADACHE. This represents approximately 3.2% of all 789 adverse event reports for this drug.
Patients taking ARNICA MONTANA who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among ARNICA MONTANA users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for ARNICA MONTANA:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 25 FDA reports for ARNICA MONTANA. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.2% of all adverse event reports for ARNICA MONTANA, making it one of the most commonly reported side effect.
If you experience headache while taking ARNICA MONTANA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.